Get the Stockscreener App
17.04
6.32%
-1.15
After Hours:
17.98
0.94
+5.52%
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Forecast
The Centessa Pharmaceuticals Plc Adr (CNTA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.7999, representing a -95.31% decrease from the current price of $17.04. The highest analyst price target is $1.5169, and the lowest is $0.083.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CNTA Price Target
Average 2.1304
(-87.50% Downside)
Is Centessa Pharmaceuticals Plc Adr (CNTA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.67 | Neutral |
| STOCH(9,6) | 48.06 | Neutral |
| STOCHRSI(14) | 23.02 | Neutral |
| MACD(12,26) | 0.4192 | Buy |
| ADX(14) | 19.66 | Neutral |
| William %R | -45.45 | Neutral |
| CCI(14) | 84.69 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
17.02
Buy
|
16.92
Buy
|
| MA20 |
16.37
Buy
|
16.58
Buy
|
| MA50 |
16.09
Buy
|
15.74
Buy
|
| MA100 |
13.88
Buy
|
14.31
Buy
|
| MA200 |
11.90
Buy
|
12.26
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, CNTA could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 0 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on CNTA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.67 indicates that CNTA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 48.06 indicates that CNTA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 23.02 indicates that CNTA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.66 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 84.69 indicates that CNTA is still overbought but not to an extreme extent.
Long-term CNTA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Centessa Pharmaceuticals Plc Adr financial reports and earnings history, Centessa Pharmaceuticals Plc Adr (CNTA) stock could reach $2.3763 by 2030, $41.62 by 2040 and $58.65 by 2050. See the projected annual prices until 2050 of the Centessa Pharmaceuticals Plc Adr stock below:
- Centessa Pharmaceuticals Plc Adr (CNTA) is expected to reach an average price of $23.13 in 2035, with a high prediction of $24.11 and a low estimate of $23.53. This indicates an $35.76% rise from the last recorded price of $17.04.
- Centessa Pharmaceuticals Plc Adr (CNTA) stock is projected to chart a bullish course in 2040, with an average price target of $41.24, representing an $142.02% surge from its current level. The forecast ranges from a conservative $41.48 to a sky-high $41.62.
- Our analysts predict Centessa Pharmaceuticals Plc Adr (CNTA) to jump 68.62% by 2045, soaring from $29.23 to an average price of $28.73, potentially reaching $29.64. While $29.23 is the low estimate, the potential upside is significant.
- Centessa Pharmaceuticals Plc Adr (CNTA) stock is expected to climb by 2050, reaching an average of $58.11, a $241.04% jump from its current level. However, a wide range of estimates exists, with high and low targets of $58.65 and $58.40, respectively, highlighting the market's uncertainty.
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Year by Year Forecast
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Price Forecast for 2024
Our forecast for CNTA stock price in 2024 now indicates an average price target of $6.2562 with a high forecast of $12.45 and a low forecast of $0.0624. The average prediction reflects an decrease of -63.29% from the last recorded price of $17.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $1.1969 | $0.083 | $1.5169 | -92.98% |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Price Forecast for 2025
Centessa Pharmaceuticals Plc Adr Stock (CNTA) is expected to reach an average price of $2.1304 in 2025, with a high prediction of $4.2341 and a low estimate of $0.0267. This indicates an -87.50% fall from the last recorded price of $17.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.8836 | $0.0267 | $1.4168 | -83.08% |
| February, 2025 | $4.934 | $3.7137 | $3.6139 | -71.04% |
| March, 2025 | $3.1744 | $3.5043 | $4.2341 | -81.37% |
| April, 2025 | $3.5749 | $2.9545 | $3.0949 | -79.02% |
| May, 2025 | $3.8252 | $3.685 | $3.6752 | -77.55% |
| June, 2025 | $3.3456 | $3.4054 | $3.3153 | -80.37% |
| July, 2025 | $3.8161 | $3.6257 | $3.4761 | -77.61% |
| August, 2025 | $3.8365 | $3.5063 | $3.6265 | -77.49% |
| September, 2025 | $3.4069 | $3.4869 | $3.6666 | -80.01% |
| October, 2025 | $3.7773 | $3.687 | $3.7023 | -77.83% |
| November, 2025 | $2.9977 | $3.2577 | $3.1024 | -82.41% |
| December, 2025 | $3.3282 | $3.4959 | $3.4781 | -80.47% |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Price Forecast for 2026
The predicted value for Centessa Pharmaceuticals Plc Adr (CNTA) in 2026 is set at an average of $1.5744. Estimates vary from a peak of $3.1171 to a trough of $0.0316, indicating an -90.76% surge from the present price of $17.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.9786 | $3.2564 | $2.9683 | -82.52% |
| February, 2026 | $1.639 | $2.769 | $2.8188 | -90.38% |
| March, 2026 | $1.8993 | $2.1892 | $1.7391 | -88.85% |
| April, 2026 | $0.6598 | $1.8398 | $1.8403 | -96.13% |
| May, 2026 | $1.3498 | $0.2833 | $2.4298 | -92.08% |
| June, 2026 | $1.6694 | $0.3809 | $2.0895 | -90.20% |
| July, 2026 | $1.729 | $0.0392 | $1.849 | -89.85% |
| August, 2026 | $0.6386 | $0.0586 | $1.7589 | -96.25% |
| September, 2026 | $0.8881 | $0.0316 | $1.7332 | -94.79% |
| October, 2026 | $1.1877 | $0.1878 | $2.1578 | -93.03% |
| November, 2026 | $1.6673 | $0.0805 | $2.2673 | -90.22% |
| December, 2026 | $2.8069 | $1.327 | $3.1171 | -83.53% |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Centessa Pharmaceuticals Plc Adr (CNTA) is $5.0199, with a high forecast of $8.5597 and a low forecast of $1.48. This indicates an -70.54% decrease from the last price of $17.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.0865 | $2.2065 | $4.2305 | -76.02% |
| February, 2027 | $5.8161 | $3.8564 | $6.8363 | -65.87% |
| March, 2027 | $5.8456 | $4.7159 | $7.5057 | -65.69% |
| April, 2027 | $4.3752 | $3.8653 | $7.3755 | -74.32% |
| May, 2027 | $2.2004 | $1.48 | $4.8851 | -87.09% |
| June, 2027 | $5.3913 | $2.7711 | $3.1713 | -68.36% |
| July, 2027 | $6.3321 | $6.5215 | $5.9321 | -62.84% |
| August, 2027 | $5.4529 | $6.0823 | $5.1329 | -68.00% |
| September, 2027 | $8.3238 | $6.683 | $8.2234 | -51.15% |
| October, 2027 | $8.2746 | $8.0744 | $7.804 | -51.44% |
| November, 2027 | $9.0953 | $8.455 | $8.5597 | -46.62% |
| December, 2027 | $7.2363 | $7.7463 | $7.9555 | -57.53% |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Price Forecast for 2028
In 2028, Centessa Pharmaceuticals Plc Adr (CNTA) is projected to reach an average price of $10.27, with a high projection of $12.37 and a low estimate of $8.1665. This indicates an -39.75% fall from the last price of $17.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.637 | $8.1665 | $7.437 | -49.31% |
| February, 2028 | $11.89 | $11.20 | $11.81 | -30.24% |
| March, 2028 | $11.22 | $11.58 | $12.37 | -34.16% |
| April, 2028 | $11.34 | $10.97 | $10.57 | -33.45% |
| May, 2028 | $11.60 | $11.55 | $11.45 | -31.92% |
| June, 2028 | $11.00 | $11.12 | $11.06 | -35.44% |
| July, 2028 | $11.06 | $11.25 | $10.82 | -35.08% |
| August, 2028 | $11.22 | $10.95 | $11.01 | -34.14% |
| September, 2028 | $10.67 | $10.75 | $11.02 | -37.36% |
| October, 2028 | $11.19 | $10.92 | $10.87 | -34.30% |
| November, 2028 | $9.9954 | $10.26 | $10.82 | -41.34% |
| December, 2028 | $10.43 | $10.46 | $10.36 | -38.81% |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Price Forecast for 2029
The 2029 price forecast for Centessa Pharmaceuticals Plc Adr Stock (CNTA) is $6.5435 on average, with a high prediction of $10.17 and a low estimate of $2.9157. This represents an -61.60% decrease from the previous price of $17.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.7071 | $10.01 | $10.17 | -43.03% |
| February, 2029 | $8.2479 | $9.3779 | $9.4875 | -51.60% |
| March, 2029 | $8.3887 | $8.6786 | $8.2883 | -50.77% |
| April, 2029 | $8.1294 | $8.3994 | $8.2698 | -52.29% |
| May, 2029 | $4.8704 | $6.5035 | $6.9796 | -71.42% |
| June, 2029 | $4.4311 | $4.741 | $4.3508 | -74.00% |
| July, 2029 | $4.4219 | $5.8219 | $5.0915 | -74.05% |
| August, 2029 | $5.1929 | $4.7752 | $5.0629 | -69.53% |
| September, 2029 | $5.2736 | $5.4336 | $5.203 | -69.05% |
| October, 2029 | $4.3746 | $4.7546 | $4.4538 | -74.33% |
| November, 2029 | $3.7753 | $4.5451 | $4.3148 | -77.84% |
| December, 2029 | $3.5461 | $2.9157 | $3.0261 | -79.19% |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Price Forecast for 2030
Centessa Pharmaceuticals Plc Adr Stock (CNTA) is expected to reach an average price of $8.585 in 2030, with a high forecast of $17.14 and a low forecast of $0.0276. This signifies an -49.62% decrease from the last price of $17.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.087 | $2.4567 | $2.3763 | -93.62% |
| February, 2030 | $0.7622 | $0.0276 | $1.7226 | -95.53% |
| March, 2030 | $1.4314 | $0.0484 | $2.5714 | -91.60% |
| April, 2030 | $0.7093 | $0.2412 | $2.501 | -95.84% |
| May, 2030 | $11.56 | $0.5297 | $10.36 | -32.16% |
| June, 2030 | $10.37 | $12.01 | $10.76 | -39.13% |
| July, 2030 | $15.42 | $15.00 | $15.02 | -9.49% |
| August, 2030 | $14.42 | $15.14 | $14.10 | -15.35% |
| September, 2030 | $17.57 | $15.62 | $17.11 | +3.08% |
| October, 2030 | $16.98 | $16.81 | $16.60 | -0.37% |
| November, 2030 | $17.68 | $17.10 | $17.14 | +3.74% |
| December, 2030 | $16.31 | $16.75 | $16.51 | -4.29% |
1.89%
2.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):